370716333	370716333	CD	B-NP	O
|	|	NN	I-NP	O
THC	THC	NN	I-NP	O
|	|	NN	I-NP	O
59702453	59702453	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1098663	1098663	CD	B-NP	O
|	|	CC	I-NP	O
4/4/2006	4/4/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/19/2006	9/19/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2006	10/20/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
MORELL	MORELL	NNP	B-NP	O
,	,	,	O	O
PARKER	PARKER	NNP	B-NP	O
L.	L.	NNP	I-NP	O
837-62-24-5	837-62-24-5	CD	I-NP	O
Verl	Verl	NNP	I-NP	O
Tri	Tri	NNP	I-NP	O
Nard	Nard	NNP	I-NP	O
,	,	,	O	O
Maryland	Maryland	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
ONC	ONC	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/8/06	11/8/06	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
SNF/rehab	SNF/rehab	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RIOJAS	RIOJAS	NNP	B-NP	O
,	,	,	O	O
HANS	HANS	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Skilled	Skille	VBN	B-VP	O
Nursing	Nurse	VBG	B-VP	O
Facility	Facility	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Temperature	Temperature	NNP	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
:	:	:	O	O
101	101	CD	B-NP	O
,	,	,	O	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
transfusion	transfusion	NN	B-NP	O
premedication	premedication	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
INH	INH	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
TESSALON	TESSALON	NNP	I-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
congestion	congestion	NN	B-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
600	600	CD	B-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NN	B-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
PERIDEX	PERIDEX	NN	I-NP	O
MOUTHWASH	MOUTHWASH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CHLORHEXIDINE	CHLORHEXIDINE	NN	I-NP	O
MOUTHWASH	MOUTHWASH	NN	I-NP	O
0.12	0.12	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
15	15	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
MO	MO	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
pls	pl	NNS	B-NP	O
use	use	VBP	B-VP	O
this	this	DT	B-NP	O
or	or	CC	I-NP	O
nystatin	nystatin	NN	I-NP	O
s	s	NN	I-NP	O
+	+	SYM	B-NP	O
s	s	NN	I-NP	O
BENADRYL	BENADRYL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DIPHENHYDRAMINE	DIPHENHYDRAMINE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
x1	x1	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
pre-transfusion	pre-transfusion	NN	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FLOVENT	FLOVENT	NNP	I-NP	O
HFA	HFA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
PROPIONATE	PROPIONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
110	110	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/9	4/9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NN	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
125	125	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
ATROVENT	ATROVENT	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
IMMED	IMMED	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NNP	B-NP	O
***	***	NNP	I-NP	O
LOW	LOW	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
REPLACEMENT	REPLACEMENT	NNP	I-NP	O
SCALE	SCALE	NNP	I-NP	O
ORAL	ORAL	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Frequency	Frequency	NNP	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
KCL	KCL	NN	I-NP	B-protein
Immediate	Immediate	JJ	I-NP	I-protein
Release	Release	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
use	use	VB	I-VP	O
sustained-release	sustained-release	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
scale	scale	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Replace	Replace	NN	B-NP	O
KCL	KCL	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
lab	lab	NN	B-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
NM	NM	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

A	A	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
ordered	order	VBN	I-VP	O
and	and	CC	O	O
checked	check	VBN	B-VP	O
daily	daily	RB	B-ADVP	O
while	while	IN	B-SBAR	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
ordered	order	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
K-scale	K-scale	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

K-scale	K-scale	NN	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
on	on	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
:	:	:	O	O
*	*	SYM	B-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
mg/dl	mg/dl	NN	I-NP	O
;	;	:	O	O
or	or	CC	O	O
*	*	SYM	B-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg/dl	mg/dl	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Hold	Hold	NN	B-NP	O
scale	scale	NN	I-NP	O
and	and	CC	O	O
contact	contact	NN	B-NP	O
MD	MD	NN	I-NP	O
if	if	IN	B-SBAR	O
SCr	SCr	NN	B-NP	B-protein
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
3.1	3.1	CD	I-NP	O
then	then	RB	B-ADVP	O
call	call	VB	B-VP	O
H.O.	H.O.	NNP	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
3.1-3	3.1-3	CD	B-NP	O
.3	.3	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
orally	orally	RB	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
20	20	CD	B-NP	O
meq	meq	NN	I-NP	O
orally	orally	RB	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	B-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
3.4-3	3.4-3	CD	B-NP	O
.6	.6	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
orally	orally	RB	B-VP	O
Recheck	Recheck	VB	I-VP	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	O	O
Level	Level	NNP	B-NP	O
is	be	VBZ	B-VP	O
3.7-4	3.7-4	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
orally	orally	RB	B-ADVP	O
Recheck	Recheck	VB	B-VP	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	O	O
Level	Level	NNP	B-NP	O
is	be	VBZ	B-VP	O
4.1-5	4.1-5	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NN	B-NP	O
NOT	NOT	NN	I-NP	O
administer	administer	NN	I-NP	O
KCL	KCL	NN	I-NP	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	B-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
in	in	IN	B-PP	O
QAM	QAM	NN	B-NP	B-protein
If	If	IN	B-SBAR	I-protein
K	K	NN	B-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
5.0	5.0	CD	B-NP	O
then	then	RB	B-ADVP	O
call	call	VB	B-VP	O
H.O.	H.O.	NNP	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
POTASSIUM	POTASSIUM	NN	I-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
SLOW	SLOW	NN	I-NP	O
REL	REL	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
EKMC	EKMC	NNP	B-NP	B-cell_type
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	B-protein
LACTULOSE	LACTULOSE	NN	I-NP	I-protein
30	30	CD	I-NP	I-protein
MILLILITERS	MILLILITERS	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Constipation	Constipation	NNP	I-NP	I-protein
ATIVAN	ATIVAN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LORAZEPAM	LORAZEPAM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
0.5-1	0.5-1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
Q8H	Q8H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
Nausea	Nausea	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sedate	sedate	NN	B-NP	O
or	or	CC	I-NP	O
rr	rr	NN	I-NP	B-protein
<	<	SYM	B-NP	I-protein
10	10	CD	B-NP	I-protein
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	I-protein
QUICK	QUICK	NNP	I-NP	I-protein
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	I-protein
1-2	1-2	NN	I-NP	I-protein
TAB	TAB	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Upset	Upset	NNP	I-NP	I-protein
Stomach	Stomach	NNP	I-NP	I-protein
MAGNESIUM	MAGNESIUM	NNP	I-NP	I-protein
GLUCONATE	GLUCONATE	NNP	I-NP	I-protein
Sliding	Sliding	NNP	I-NP	I-protein
Scale	Scale	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
orally	orally	RB	B-ADVP	O
-RRB-	-RRB-	HYPH	B-NP	O
DAILY	DAILY	NN	I-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
Mg-scales	Mg-scale	NNS	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
doses	dose	NNS	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
individualized	individualize	VBN	I-VP	O
for	for	IN	B-PP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
have	have	VBP	B-VP	O
:	:	:	O	O
-	-	:	O	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
;	;	:	O	O
or	or	CC	O	O
-	-	:	O	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Call	Call	NN	B-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
0.8	0.8	CD	I-NP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
1.0-1	1.0-1	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
1.6-1	1.6-1	CD	B-NP	O
.9	.9	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Gluconate	Gluconate	NN	I-NP	O
orally	orally	RB	B-ADVP	O
If	If	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
2.0-2	2.0-2	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Do	Do	VBP	B-VP	O
Not	Not	RB	I-VP	O
administer	administer	VB	I-VP	O
Mg	Mg	NN	B-NP	O
Gluconate	Gluconate	NN	I-NP	O
Call	Call	NN	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
2.5	2.5	CD	I-NP	O
MAGNESIUM	MAGNESIUM	NN	I-NP	O
SULFATE	SULFATE	NN	I-NP	O
Sliding	Slide	VBG	B-VP	O
Scale	Scale	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
intravenously	intravenously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
DAILY	DAILY	NNP	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Physician	Physician	NN	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Magnesium	Magnesium	NN	B-NP	O
scales	scale	NNS	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
on	on	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
;	;	:	O	O
or	or	CC	O	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg/dL	mg/dL	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Call	Call	VB	B-VP	O
HO	HO	NN	B-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1.2	1.2	CD	I-NP	O
Hold	Hold	NNP	I-NP	O
order	order	NN	I-NP	O
if	if	IN	B-SBAR	O
creatinine	creatinine	NN	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
1.9	1.9	CD	B-NP	O
If	If	IN	B-SBAR	O
serum	serum	NN	B-NP	O
Mg	Mg	NN	I-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
5	5	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Sulfate	Sulfate	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	O
If	If	IN	B-SBAR	O
serum	serum	NN	B-NP	O
Mg	Mg	NN	I-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
serum	serum	NN	B-NP	O
Mg	Mg	NN	I-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1.8	1.8	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Sulfate	Sulfate	NN	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
serum	serum	NN	B-NP	O
Mg	Mg	NN	I-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
2.0	2.0	CD	I-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
gm	gm	NN	I-NP	O
Mg	Mg	NN	I-NP	O
Sulfate	Sulfate	NN	I-NP	O
intravenously	intravenously	RB	B-VP	O
Call	Call	VB	I-VP	O
HO	HO	NN	B-NP	O
if	if	IN	B-SBAR	O
Mg	Mg	NN	B-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2.5	2.5	CD	B-NP	O
MS	MS	NNP	I-NP	O
CONTIN	CONTIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MORPHINE	MORPHINE	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/9	4/9	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
rr	rr	NN	B-NP	O
<	<	JJR	I-NP	O
10	10	CD	I-NP	O
or	or	CC	I-NP	O
very	very	RB	I-NP	O
sleepy	sleepy	JJ	I-NP	O
NYSTATIN	NYSTATIN	NN	I-NP	O
SUSPENSION	SUSPENSION	NN	I-NP	O
10	10	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
use	use	VB	B-VP	O
this	this	DT	B-NP	O
or	or	CC	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
ZOFRAN	ZOFRAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
POST-OP	POST-OP	NN	I-NP	O
N/V	N/V	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ONDANSETRON	ONDANSETRON	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
POST	POST	NN	I-NP	O
-	-	HYPH	B-ADJP	O
...	...	:	O	B-DNA
-RRB-	-RRB-	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
IV	IV	CD	B-NP	I-DNA
Q6H	Q6H	NN	I-NP	I-DNA
X	X	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Nausea	Nausea	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
***	***	NNP	I-NP	O
MODERATE	MODERATE	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
REPLACEMENT	REPLACEMENT	NNP	I-NP	O
SCALE	SCALE	NNP	I-NP	O
10	10	CD	I-NP	O
mEq/HR	mEq/HR	NN	I-NP	O
IV	IV	CD	I-NP	O
Scale	Scale	NNP	I-NP	O
Frequency	Frequency	NNP	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Replace	Replace	NN	B-NP	O
KCL	KCL	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
lab	lab	NN	B-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

An	An	DT	B-NP	O
infusion	infusion	NN	I-NP	O
pump	pump	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
intermittent	intermittent	JJ	I-NP	O
bolus	bolus	NN	I-NP	O
infusions	infusion	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

KCL	KCL	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mEq/100ml/hr	mEq/100ml/hr	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
intermittent	intermittent	JJ	B-NP	O
bolus	bolus	NN	I-NP	O
infusion	infusion	NN	I-NP	O
standard	standard	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

A	A	DT	B-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
ordered	order	VBN	I-VP	O
and	and	CC	O	O
checked	check	VBN	B-VP	O
daily	daily	RB	B-ADVP	O
while	while	IN	B-SBAR	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
ordered	order	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
K-scale	K-scale	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

K-scale	K-scale	NN	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
on	on	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
:	:	:	O	O
*	*	SYM	B-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
mg/dl	mg/dl	NN	I-NP	O
;	;	:	O	O
or	or	CC	O	O
*	*	SYM	B-NP	O
A	A	NN	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg/dl	mg/dl	NN	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Hold	Hold	NN	B-NP	O
scale	scale	NN	I-NP	O
and	and	CC	O	O
contact	contact	NN	B-NP	O
MD	MD	NN	I-NP	O
if	if	IN	B-SBAR	O
SCr	SCr	NN	B-NP	B-protein
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
3.1	3.1	CD	I-NP	O
then	then	RB	B-ADVP	O
call	call	VB	B-VP	O
H.O.	H.O.	NNP	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
3.1-3	3.1-3	CD	B-NP	O
.3	.3	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
x5	x5	NN	I-NP	I-protein
Recheck	Recheck	NN	I-NP	I-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-VP	O
Level	Level	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-SBAR	O
infusion	infusion	NN	B-NP	O
finished	finish	VBD	B-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
3.4-3	3.4-3	CD	B-NP	O
.6	.6	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
x4	x4	NN	I-NP	I-protein
Recheck	Recheck	NN	I-NP	I-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-VP	O
Level	Level	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-SBAR	O
infusion	infusion	NN	B-NP	O
finished	finish	VBD	B-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	O	O
Level	Level	NNP	B-NP	O
is	be	VBZ	B-VP	O
3.7-4	3.7-4	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
Recheck	Recheck	NN	I-NP	I-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-VP	O
Level	Level	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-SBAR	O
infusion	infusion	NN	B-NP	O
finished	finish	VBD	B-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
4.1-4	4.1-4	CD	B-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
administer	administer	IN	B-PP	O
KCL	KCL	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
meq	meq	NN	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
Recheck	Recheck	NN	I-NP	I-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-VP	O
Level	Level	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-SBAR	O
infusion	infusion	NN	B-NP	O
finished	finish	VBD	B-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
K	K	NN	B-NP	O
+	+	SYM	O	O
Level	Level	NNP	B-NP	O
is	be	VBZ	B-VP	O
4.6-5	4.6-5	CD	B-NP	O
.0	.0	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NN	B-NP	O
NOT	NOT	NN	I-NP	O
administer	administer	NN	I-NP	O
KCL	KCL	NN	I-NP	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	B-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
in	in	IN	B-PP	O
QAM	QAM	NN	B-NP	B-protein
If	If	IN	B-SBAR	I-protein
K	K	NN	B-NP	I-protein
+	+	SYM	B-NP	O
Level	Level	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
5.0	5.0	CD	B-NP	O
then	then	RB	B-ADVP	O
call	call	VB	B-VP	O
H.O.	H.O.	NNP	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
ZOLOFT	ZOLOFT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SERTRALINE	SERTRALINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/9	4/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/3/06	8/3/06	CD	B-NP	O
by	by	IN	B-PP	O
HAGON	HAGON	NNP	B-NP	O
,	,	,	O	O
AUBREY	AUBREY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEODON	GEODON	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
134059385	134059385	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SERTRALINE	SERTRALINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
ZIPRASIDONE	ZIPRASIDONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
5	5	CD	I-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
VANCOMYCIN	VANCOMYCIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
1	1	CD	I-NP	O
GM	GM	NNP	I-NP	O
IV	IV	CD	I-NP	O
Q12H	Q12H	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
plan	plan	NN	B-NP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
started	start	VBD	B-VP	O
3/4	3/4	CD	B-NP	O
,	,	,	O	O
end	end	NN	B-NP	O
11/14	11/14	CD	I-NP	O
COMPAZINE	COMPAZINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PROCHLORPERAZINE	PROCHLORPERAZINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Nausea	Nausea	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/8/06	11/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
IPRATROPIUM	IPRATROPIUM	NNP	B-NP	O
BROMIDE	BROMIDE	NNP	I-NP	O
&	&	CC	I-NP	O
PROCHLORPERAZINE	PROCHLORPERAZINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
pls	pl	NNS	B-NP	O
f/u	f/u	VBP	B-VP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
oncologist	oncologist	NN	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
hypotension	hypotension	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
iddm	iddm	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ccy	ccy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
metastatic	metastatic	JJ	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
na	na	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Tachycardia	Tachycardia	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
from	from	IN	B-PP	O
Vi	Vi	NNP	B-NP	O
Ca	Ca	NNP	I-NP	O
Beth	Beth	NNP	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
since	since	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
elicit	elicit	VB	I-VP	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
story	story	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
cough	cough	NN	B-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
variably	variably	RB	B-NP	O
colored	color	VBN	I-NP	O
sputum	sputum	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
yellow	yellow	VBP	B-VP	O
to	to	TO	I-VP	O
green	green	VB	I-VP	O
to	to	TO	I-VP	O
orange	orange	VB	I-VP	O
,	,	,	O	O
without	without	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
but	but	CC	O	O
it	it	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
cough	cough	NN	I-NP	O
for	for	IN	B-PP	O
months	month	NNS	B-NP	O
.	.	.	O	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
notes	note	VBZ	B-VP	O
dysuria	dysuria	NN	B-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
frequency	frequency	NN	I-NP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
present	present	JJ	B-ADJP	O
for	for	IN	B-SBAR	O
weeks	week	NNS	B-NP	O
to	to	TO	B-PP	O
months	month	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
short	short	JJ	B-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
hemoptysis	hemoptysis	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
numbness	numbness	NN	B-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
rash	rash	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
bumps	bump	NNS	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
wall	wall	NN	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
painful-it	painful-it	JJ	B-NP	O
sounds	sound	NNS	I-NP	O
like	like	IN	B-PP	O
these	these	DT	B-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enoxaprin	enoxaprin	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
getting	get	VBG	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ZH	ZH	NN	I-NP	B-protein
ER	ER	NN	I-NP	I-protein
doctor	doctor	NN	I-NP	O
spoke	speak	VBD	B-VP	O
with	with	IN	B-PP	O
Senz	Senz	NNP	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
x-ray	x-ray	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
referral	referral	JJ	I-NP	O
states	state	NNS	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o	p.o	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
FMC	FMC	NN	I-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hydrated	hydrate	VBN	I-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
still	still	RB	B-ADVP	O
remains	remain	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
130s	130	NNS	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Levofloxacin	Levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
physician	physician	NN	I-NP	O
was	be	VBD	B-VP	O
worried	worry	VBN	B-ADJP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
do	do	VB	I-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
here	here	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Chamvine	Chamvine	NNP	I-NP	O
Tionbradvar	Tionbradvar	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MRA	MRA	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
PE	PE	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
here	here	RB	B-ADVP	O
,	,	,	O	O
IJ	IJ	NN	B-NP	O
central	central	JJ	I-NP	O
line	line	NN	I-NP	O
placed	place	VBD	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
CVP	CVP	NN	I-NP	O
~	~	VBP	B-VP	O
20	20	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	JJ	I-NP	O
given	give	VBN	I-NP	O
1L	1L	NN	I-NP	O
NS	NS	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
systolic	systolic	JJ	B-ADJP	O
initially	initially	RB	B-ADVP	O
120s	120s	CD	B-NP	O
but	but	CC	O	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
90s	90s	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
MAPS	MAPS	NN	I-NP	O
>	>	SYM	B-NP	O
70	70	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
,	,	,	O	O
and	and	CC	O	O
norepinephrine	norepinephrine	NN	B-NP	O
started	start	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
NE	NE	NN	I-NP	B-protein
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
promptly	promptly	RB	B-NP	O
given	give	VBN	I-NP	O
BP	BP	NN	I-NP	O
improvement	improvement	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
continued	continue	VBN	B-NP	O
SBP	SBP	NN	I-NP	B-protein
>	>	SYM	O	O
100	100	CD	B-NP	O
PAST	PAST	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Metastatic	Metastatic	JJ	B-NP	O
breast	breast	NN	I-NP	O
CA-bone	CA-bone	NN	I-NP	O
scan	scan	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
widespread	widespread	JJ	B-NP	O
osseous	osseous	JJ	I-NP	O
metastasis	metastasis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CNS	CNS	NN	B-NP	B-protein
involvement	involvement	NN	I-NP	O
on	on	IN	B-PP	O
head	head	NN	B-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
bx	bx	NN	I-NP	O
with	with	IN	B-PP	O
invasive	invasive	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
brain	brain	NN	I-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
1/2	1/2	CD	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
PE	PE	NN	B-NP	B-protein
10/06	10/06	CD	I-NP	I-protein
,	,	,	O	O
tx	tx	NN	B-NP	O
with	with	IN	B-PP	O
enoxaprin	enoxaprin	NN	B-NP	O
through	through	IN	B-PP	O
4/06	4/06	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
discontinued	discontinue	VBN	B-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
doubt	doubt	NN	B-NP	O
over	over	IN	B-PP	O
original	original	JJ	B-NP	O
dx	dx	NN	I-NP	O
and	and	CC	O	O
significant	significant	JJ	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
injection	injection	NN	B-NP	O
sites	site	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
arthritis	arthritis	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
obesity	obesity	NN	B-NP	O
.	.	.	O	O

ONC	ONC	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
grade	grade	NN	B-NP	B-protein
III	III	CD	I-NP	I-protein
,	,	,	O	O
ER/PR/HER2-negative	ER/PR/HER2-negative	JJ	B-ADJP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2004	2004	CD	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
January	January	NNP	B-NP	O
2004	2004	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
right	right	JJ	B-NP	O
breast	breast	NN	I-NP	O
lumpectomy	lumpectomy	NN	I-NP	O
with	with	IN	B-PP	O
pathology	pathology	NN	B-NP	O
demonstrating	demonstrate	VBG	B-VP	O
4.1	4.1	CD	B-NP	O
cm	cm	NN	I-NP	O
IDC	IDC	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LVI	LVI	NNP	I-NP	O
,	,	,	I-NP	O
negative	negative	JJ	I-NP	O
sentinel	sentinel	NN	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
partial	partial	JJ	B-NP	O
breast	breast	NN	I-NP	O
radiation	radiation	NN	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
2004	2004	CD	I-NP	O
and	and	CC	O	O
deferred	defer	VBN	B-VP	O
on	on	IN	B-PP	O
adjuvant	adjuvant	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
August	August	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
wall	wall	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	I-NP	O
imaging	imaging	NN	I-NP	O
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
nodules	nodule	NNS	I-NP	O
,	,	,	O	O
thoracic	thoracic	JJ	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
bone	bone	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
wide	wide	JJ	B-NP	O
spread	spread	VBN	I-NP	O
osseous	osseous	JJ	I-NP	O
metastatic	metastatic	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
head	head	NN	B-NP	O
CT	CT	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
CNS	CNS	NN	I-NP	B-protein
involvement	involvement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
whole	whole	JJ	B-NP	O
brain	brain	NN	I-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
weekly	weekly	JJ	B-NP	O
Taxol	Taxol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
through	through	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
.	.	.	O	O

Restaging	Restaging	NN	B-NP	O
studies	study	NNS	I-NP	O
showed	show	VBD	B-VP	O
stable	stable	JJ	B-NP	O
visceral	visceral	JJ	I-NP	O
disease	disease	NN	I-NP	O
but	but	CC	O	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
bony	bony	JJ	B-NP	O
metastatic	metastatic	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
initiated	initiate	VBD	B-VP	O
a	a	DT	B-NP	O
second-line	second-line	JJ	I-NP	O
Navelbine	Navelbine	NNP	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
99.3	99.3	CD	I-NP	O
po	po	NN	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
112	112	CD	I-NP	O
regular	regular	JJ	I-NP	O
,	,	,	I-NP	O
BP	BP	NN	I-NP	B-DNA
120/75	120/75	CD	I-NP	I-DNA
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
18	18	CD	B-NP	O
,	,	,	O	O
sO2	sO2	NN	B-NP	O
=	=	SYM	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
ambient	ambient	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	JJ	B-NP	O
APPEARANCE	APPEARANCE	NN	I-NP	O
:	:	:	O	O
Laying	Lay	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
coughing	cough	VBG	B-VP	O
paroxysms	paroxysm	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
accessory	accessory	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Mucosa	Mucosa	NNP	B-NP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
jaundice	jaundice	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
conjunctival	conjunctival	JJ	B-NP	O
pallor	pallor	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
reactive	reactive	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
and	and	CC	I-NP	O
nontender	nontender	NN	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	B-protein
IJ	IJ	NN	I-NP	I-protein
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
heaves	heave	NNS	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NNS	B-NP	O
:	:	:	O	O
Crackles	Crackle	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
chest	chest	NN	I-NP	O
posteriorly	posteriorly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
diffuse	diffuse	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

Small	Small	JJ	B-NP	O
nodule	nodule	NN	I-NP	O
RUQ	RUQ	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
,	,	,	O	O
mildly	mildly	RB	B-NP	O
tender	tender	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

BACK	BACK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CVAT	CVAT	NN	I-NP	B-protein
.	.	.	O	O

NEUROLOGIC	NEUROLOGIC	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
&	&	CC	I-NP	B-protein
O	O	NNP	I-NP	I-protein
x4	x4	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
somewhat	somewhat	RB	B-ADJP	O
sedate	sedate	NN	I-ADJP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
attention	attention	NN	I-NP	O
.	.	.	O	O

Radial	Radial	NN	B-NP	O
and	and	CC	I-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
and	and	CC	I-NP	O
strength	strength	NN	I-NP	O
are	be	VBP	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
calf	calf	NN	I-NP	O
warmth	warmth	NN	I-NP	O
,	,	,	O	O
erythema	erythema	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
tenderness	tenderness	NN	B-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
right	right	JJ	I-NP	O
heel	heel	NN	I-NP	O
and	and	CC	O	O
Achilles	Achilles	NNP	B-NP	O
tendon	tendon	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
RESULTS	RESULTS	NNS	I-NP	O
AT	AT	NNP	I-NP	O
DMC	DMC	NNP	I-NP	O
WBC	WBC	NNP	I-NP	O
3.2	3.2	CD	I-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
7.5	7.5	CD	I-NP	O
MCV	MCV	NN	I-NP	O
=	=	SYM	B-VP	O
76	76	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
482	482	CD	B-NP	I-protein
,	,	,	O	O
neutrophils	neutrophil	VBZ	B-VP	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.2	3.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
122	122	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
17	17	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
20	20	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
181	181	CD	I-NP	O
.	.	.	O	O

LDH	LDH	NN	B-NP	B-protein
542	542	CD	I-NP	I-protein
,	,	,	O	O
Ca	Ca	NNP	B-NP	O
6.7	6.7	CD	I-NP	O
Alb	Alb	NNP	I-NP	O
2.2	2.2	CD	I-NP	O
Urinalysis	Urinalysis	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
heme	heme	NN	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
25-50	25-50	CD	I-NP	O
,	,	,	O	O
RBC	RBC	NN	B-NP	O
15-25	15-25	CD	I-NP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	B-protein
1	1	CD	I-NP	I-protein
+	+	SYM	O	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
nitrites	nitrite	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
2.0	2.0	CD	I-NP	O
PTT	PTT	NN	I-NP	O
43.3	43.3	CD	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
RESULTS	RESULTS	NNS	I-NP	O
AT	AT	NNP	I-NP	O
MR	MR	NNP	I-NP	O
WBC	WBC	NNP	I-NP	O
3.5	3.5	CD	I-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
592	592	CD	B-NP	I-protein
,	,	,	O	O
neutrophils	neutrophil	VBZ	B-VP	O
68	68	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
142	142	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.5	3.5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
111	111	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
23	23	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
217	217	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
261	261	CD	I-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	B-DNA
26	26	CD	I-NP	I-DNA
,	,	,	O	O
ALT	ALT	NN	B-NP	O
27	27	CD	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
:	:	:	O	O
Large	Large	JJ	B-NP	O
heme	heme	NN	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
6-10	6-10	CD	I-NP	O
,	,	,	O	O
RBC	RBC	NN	B-NP	O
0-2	0-2	CD	I-NP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
trace	trace	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
:	:	:	O	O
Pending	Pending	NNP	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
9/3/06	9/3/06	CD	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
growth	growth	NN	I-NP	O
Chest	Chest	NNP	I-NP	O
x-ray	x-ray	NNP	I-NP	O
:	:	:	O	O
Revealed	Reveal	VBD	B-VP	O
questionable	questionable	JJ	B-NP	O
left	left	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
with	with	IN	B-PP	O
metastasis	metastasis	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
120	120	CD	B-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
LLL	LLL	NN	B-NP	O
opacity	opacity	NN	I-NP	O
,	,	,	O	O
LUL	LUL	NN	B-NP	O
opacity	opacity	NN	I-NP	O
.	.	.	O	O

Hilar	Hilar	JJ	B-NP	O
fullness	fullness	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
righT	righT	NN	I-NP	O
>	>	SYM	B-NP	O
l	l	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
prominent	prominent	JJ	B-NP	O
bronchi	bronchi	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
?	?	.	O	O

cuffing	cuff	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
on	on	IN	B-PP	O
right	right	NN	B-NP	O
.	.	.	O	O

Vertebral	Vertebral	JJ	B-NP	O
fractures	fracture	NNS	I-NP	O
.	.	.	O	O

LLL	LLL	NN	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
8/27	8/27	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
LUL	LUL	NNP	B-NP	O
improved	improve	VBD	B-VP	O
C/w	C/w	NNP	B-NP	O
known	know	VBN	B-VP	O
metastatic	metastatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
,	,	,	I-NP	O
lethargy	lethargy	NN	I-NP	O
,	,	,	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
and	and	CC	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
dysuria	dysuria	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
chronicity	chronicity	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
issues	issue	NNS	I-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
growing	grow	VBG	B-VP	O
1	1	CD	B-NP	O
bottle	bottle	NN	I-NP	O
from	from	IN	B-PP	O
WBH	WBH	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
NBH	NBH	NN	B-NP	O
of	of	IN	B-PP	O
GPC	GPC	NN	B-NP	B-protein
in	in	IN	B-PP	O
clusters	cluster	NNS	B-NP	O
empirically	empirically	RB	B-ADVP	O
on	on	IN	B-PP	O
Vanco	Vanco	NNP	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
looks	look	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
coag	coag	NN	B-NP	O
neg.Discussed	neg.Discusse	VBN	B-VP	O
with	with	IN	B-PP	O
ID	ID	NN	B-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
like	like	VB	I-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
vanco	vanco	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
Tachycardia	Tachycardia	NN	I-NP	O
:	:	:	O	O
Most	Most	JJS	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
either	either	CC	O	O
pulmonary	pulmonary	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
urinary	urinary	JJ	I-ADJP	O
.	.	.	O	O

With	With	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
Cr	Cr	NN	B-NP	O
PE	PE	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative.Stable	negative.Stable	JJ	B-ADJP	O
.	.	.	O	O

d/c	d/c	NN	B-NP	O
ASA	ASA	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
as	as	IN	B-PP	O
no	no	DT	B-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
risk	risk	NN	I-NP	O
reduction	reduction	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
Cough	Cough	NN	I-NP	O
:	:	:	O	O
Productive	Productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
yellow	yellow	JJ	B-ADJP	O
to	to	TO	B-PP	O
green	green	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

Seems	Seem	NNS	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
present	present	JJ	B-ADJP	O
for	for	IN	B-PP	O
months	month	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
how	how	WRB	B-ADVP	O
much	much	RB	I-ADVP	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
changed	change	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

May	May	MD	B-VP	O
be	be	VB	I-VP	O
chronic	chronic	JJ	B-ADJP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
tumor	tumor	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
acute	acute	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Aspiration	Aspiration	NN	B-NP	O
plausible	plausible	JJ	I-NP	O
given	give	VBN	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
CT	CT	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
any	any	DT	B-NP	O
acute	acute	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
Dysuria	Dysuria	NN	I-NP	O
:	:	:	O	O
Again	Again	NN	B-NP	O
,	,	,	O	O
chronicity	chronicity	NN	B-NP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
at	at	IN	B-PP	O
HNH	HNH	NN	B-NP	B-protein
not	not	RB	O	O
very	very	RB	B-ADJP	O
suggestive	suggestive	JJ	I-ADJP	O
of	of	IN	B-PP	O
UTI	UTI	NN	B-NP	B-DNA
,	,	,	O	O
but	but	CC	O	O
UA	UA	NNP	B-NP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
25	25	CD	B-NP	O
wbc	wbc	NN	I-NP	O
and	and	CC	I-NP	O
LE	LE	NN	I-NP	O
+	+	SYM	B-NP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
been	be	VBN	B-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
so	so	RB	B-ADVP	O
will	will	MD	B-VP	O
treat	treat	VB	I-VP	O
until	until	IN	B-SBAR	O
cultures	culture	NNS	B-NP	O
return	return	VBP	B-VP	O
with	with	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
d/c	d/c	NN	I-NP	I-protein
10/20	10/20	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

*	*	SYM	O	O
Bacteremia	Bacteremia	NN	B-NP	O
:	:	SYM	O	O
coag	coag	NN	B-NP	O
neg	neg	NN	I-NP	O
staph	staph	NN	I-NP	O
x2	x2	NN	I-NP	O
,	,	,	O	O
Vanc	Vanc	NNP	B-NP	O
Sens	Sens	NNP	I-NP	O
,	,	,	O	O
plan	plan	VBP	B-VP	O
to	to	TO	I-VP	O
treat	treat	VB	I-VP	O
via	via	IN	B-PP	O
PICC	PICC	NN	B-NP	O
w/Vancomycin	w/Vancomycin	NN	I-NP	O
x14days	x14day	NNS	I-NP	O
*	*	SYM	O	O
Oncology	Oncology	NNP	B-NP	O
:	:	:	O	O
Discussion	Discussion	NNP	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Clusky	Clusky	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
oncologic	oncologic	JJ	I-NP	O
fellow	fellow	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
from	from	IN	B-PP	O
my	my	PRP$	B-NP	O
description	description	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
sound	sound	VB	I-VP	O
much	much	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
mildly	mildly	RB	B-ADJP	O
tachycardic	tachycardic	JJ	I-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
although	although	IN	B-SBAR	O
not	not	RB	O	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
degree	degree	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	I-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
ARF	ARF	NN	B-NP	B-protein
,	,	,	O	O
improving	improve	VBG	B-VP	O
with	with	IN	B-PP	O
IVF	IVF	NN	B-NP	B-protein
.	.	.	O	O

Likely	Likely	RB	B-NP	O
prerenal	prerenal	JJ	I-NP	O
azotemia	azotemia	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
1UPRBC	1UPRBC	NN	I-NP	O
in	in	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
.	.	.	O	O

Unfortuantely	Unfortuantely	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
before	before	IN	B-PP	O
hemolysis	hemolysis	NN	B-NP	O
or	or	CC	I-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
sent	send	VBN	B-VP	O
.	.	.	O	O

Would	Would	MD	B-VP	O
be	be	VB	I-VP	O
indicated	indicate	VBN	I-VP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
setting	set	VBG	B-NP	O
of	of	IN	B-PP	O
markedly	markedly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

Should	Should	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
in	in	IN	B-PP	O
future	future	NN	B-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	I-VP	O
added	add	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
manual	manual	JJ	I-NP	O
blood	blood	NN	I-NP	O
smear	smear	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	B-protein
INR	INR	NN	I-NP	I-protein
similarly	similarly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
but	but	CC	O	O
I	I	PRP	B-NP	O
believe	believe	VBP	B-VP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
enoxaprin	enoxaprin	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
.	.	.	O	O

Not	Not	RB	O	O
on	on	IN	B-PP	O
enoxaprin	enoxaprin	NN	B-NP	O
or	or	CC	I-NP	O
warfarin	warfarin	NN	I-NP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

May	May	MD	B-VP	O
be	be	VB	I-VP	O
dues	due	NNS	B-NP	O
to	to	TO	B-PP	O
malnutrition	malnutrition	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
DIC	DIC	NN	B-NP	O
or	or	CC	I-NP	O
liver	liver	NN	I-NP	B-protein
disease.Administered	disease.Administere	VBN	I-NP	I-protein
vitamin	vitamin	NN	I-NP	I-protein
K.	K.	NNP	B-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
Resumed	Resume	VBN	B-NP	O
home	home	NN	I-NP	O
zoloft	zoloft	NN	I-NP	O
,	,	,	O	O
restart	restart	VB	B-VP	O
geodon	geodon	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Goals	Goal	NNS	B-NP	O
of	of	IN	B-PP	O
care	care	NN	B-NP	O
:	:	:	O	O
Discussed	Discuss	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Pinion	Pinion	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
expresses	express	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
wants	want	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
intubated	intubate	VBN	I-VP	O
or	or	CC	O	O
have	have	VBP	B-VP	O
defibrillation	defibrillation	NN	B-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Ellestad	Ellestad	NNP	I-NP	O
has	have	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O
this	this	DT	B-NP	O
numerous	numerous	JJ	I-NP	O
times	time	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
readdress	readdress	VB	I-VP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
oncologist	oncologist	NN	I-NP	O
call	call	NN	I-NP	O
oncologist	oncologist	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-VP	O
ed	ed	VBN	I-VP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
FENCEROY	FENCEROY	NNP	B-NP	O
,	,	,	O	O
TAYLOR	TAYLOR	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NM201	NM201	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/8/06	11/8/06	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
03	03	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

